Event Details


Biologic Interventions for Spinal Pathologies: Stem Cells, Growth Factors and Novel Therapeutics (non-CME)

Virtual

Starts: Wed 7:30AM MST (Feb 09, 2022) Ends: Wed 6:30PM MST (Feb 09, 2022) OnDemand

View Agenda Register Now

The field of spinal biologics is rapidly evolving as patients, researchers, and clinicians are recognizing its potential to treat challenging painful conditions. While the roles of both nonoperative and surgical treatment are relatively well-defined in the algorithm of spine care, the indications, risks, and concerns regarding biologics for a variety of spinal conditions have not been agreed upon. Because of the differences in regulatory pathways for many of these products, the availability of data is variable making administrative decision-making difficult. This meeting will bring together exciting minds from academia and industry to discuss the pertinent technologies and relevant issues in biologics use for spinal conditions.

This is a non-CME event.

Disclaimer

NASS courses are created to enhance physician understanding of the complexity of performing these procedures only. The course is not designed to certify that attendees are proficient in the procedures taught in the course. NASS strongly advises participants to continue to have proctoring, mentoring and additional experience prior to treating patients.

Co-Chairs

Harvey E. Smith, MD

Raymond Hah, MD

Audience

Local, national and international spine surgeons, nonoperative healthcare providers, industry, researchers, patients and related clinicians.


 Price LevelRegistration Fees
Collapse group

Registration: General Registration

 Member$250.00
 Non-Member$250.00

Location

Online
Virtual,
US


Continuing Medical Education (CME)s

This is a non-CME event.


Have A Question?

We want to make sure that your registration process is a pleasant one, so if you have any trouble or a question, please email or call us at (630) 230-3600.